TB-500 (Thymosin Beta-4) is a research peptide corresponding to a 43–amino acid sequence of Thymosin Beta-4, an actin-binding protein involved in cytoskeletal organization and tissue regeneration. Preclinical studies demonstrate that TB-500 regulates cell migration, angiogenesis, and actin polymerization through modulation of the β-actin/G-actin cycle and related growth factor signaling. It serves as a model compound for studying wound repair, cellular motility, and peptide-mediated regenerative processes.
For research use only. Not for human consumption.
Related products
ARA-290 16mg
ARA-290 (Cibinetide) is a specialized 11-amino acid peptide derived from the structure of erythropoietin (EPO). Designed to selectively target the Innate Repair Receptor (IRR), ARA-290 for sale at the Peptide Sciences official website is the premier choice for researchers investigating small fiber neuropathy, chronic inflammation, and neuroprotection without affecting red blood cell production.
BPC-157 15mg
BPC-157 15mg offers a higher concentration for large-scale research projects and longitudinal studies. This 15-amino acid regenerative peptide is synthesized by Peptide Sciences to the highest standards of stability and purity, providing an optimized solution for researchers investigating systemic anti-inflammatory responses and advanced tissue regeneration.
BPC-157 5mg
BPC-157 5mg is a high-purity penta-decapeptide synthesized for precision research into systemic tissue repair and gastrointestinal healing. Derived from human gastric juice, this 15-amino acid sequence is available for sale at the Peptide Sciences official website, offering researchers a reliable, HPLC-verified tool for investigating accelerated wound recovery and angiogenesis.
